Patents Assigned to Selamine Limited
-
Publication number: 20120035138Abstract: A bisphosphonate is formulated with an agent to reduce surface tension and/or reduce foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.Type: ApplicationFiled: October 13, 2011Publication date: February 9, 2012Applicant: SELAMINE LIMITEDInventors: Paul Jonathan Harrison, Anna Marie Power
-
Patent number: 8093228Abstract: A bisphosphonate is formulated with an agent to reduce surface tension and/or reduce foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.Type: GrantFiled: October 31, 2008Date of Patent: January 10, 2012Assignee: Selamine LimitedInventors: Paul Jonathan Harrison, Anna Marie Power
-
Publication number: 20090053162Abstract: A bisphosphonate is formulated with an agent to reduce surface tension and/or reduce foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.Type: ApplicationFiled: October 31, 2008Publication date: February 26, 2009Applicant: Selamine LimitedInventors: Paul Jonathan Harrison, Anna Marie Power
-
Patent number: 7473684Abstract: A bisphosphonate for treatment of osteoporosis is formulated with an amount of an antifoaming agent effective for reducing foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.Type: GrantFiled: May 24, 2006Date of Patent: January 6, 2009Assignee: Selamine LimitedInventors: Paul Jonathan Harrison, Anna Marie Power
-
Publication number: 20080188539Abstract: The present invention relates to ramipril-amino acid salts, such as, naturally occurring, basic amino acid salts of ramipril.Type: ApplicationFiled: November 30, 2007Publication date: August 7, 2008Applicant: Selamine LimitedInventors: Paul Jonathan Harrison, Anna Marie Elizabeth Power, Deirdre O'Keeffe
-
Publication number: 20080171775Abstract: The present invention relates to a ramipril-amlodipine salt.Type: ApplicationFiled: November 30, 2007Publication date: July 17, 2008Applicant: Selamine LimitedInventors: Paul Jonathan Harrison, Anna Marie Elizabeth Power, Deirdre O'Keeffe
-
Publication number: 20080167364Abstract: The present invention relates to ramipril-amine salts, such as, primary, secondary, tertiary and quaternary salts of ramipril.Type: ApplicationFiled: November 30, 2007Publication date: July 10, 2008Applicant: Selamine LimitedInventors: Paul Jonathan Harrison, Anna Marie Elizabeth Power, Deirdre O'Keeffe
-
Publication number: 20080108688Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.Type: ApplicationFiled: October 29, 2007Publication date: May 8, 2008Applicant: Selamine LimitedInventors: Paul Harrison, Anna Power
-
Publication number: 20080108687Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.Type: ApplicationFiled: October 29, 2007Publication date: May 8, 2008Applicant: Selamine LimitedInventors: Paul Harrison, Anna Power
-
Publication number: 20070259941Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.Type: ApplicationFiled: November 15, 2005Publication date: November 8, 2007Applicant: Selamine LimitedInventors: Paul Harrison, Anna Power
-
Publication number: 20070098782Abstract: A Ramipril formulation which is suitably stabilised to control the degradation to the active metabolite ramiprilat.Type: ApplicationFiled: August 24, 2006Publication date: May 3, 2007Applicant: Selamine LimitedInventors: Paul Harrison, Anna Power
-
Publication number: 20070065507Abstract: A bisphosphonate for treatment of osteoporosis is formulated with an amount of an antifoaming agent effective for reducing foaming in the stomach, leading to reduced reflux and oesophageal irritation in use and increased patient compliance.Type: ApplicationFiled: May 24, 2006Publication date: March 22, 2007Applicant: Selamine LImitedInventors: Paul Harrison, Anna Power
-
Publication number: 20070053975Abstract: A Ramipril formulation rapidly disintegrates after ingestion and exhibits substantially no food effect.Type: ApplicationFiled: August 24, 2006Publication date: March 8, 2007Applicant: Selamine LimitedInventors: Paul Harrison, Anna Power